Evidence map›Paper›PMID 32580712›Full record

ArticleBMC medical genetics2020

Ancestry effects on type 2 diabetes genetic risk inference in Hispanic/Latino populations.

Aroon T Chande, Lavanya Rishishwar, Andrew B Conley, Augusto Valderrama-Aguirre, Miguel A Medina-Rivas, I King Jordan

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Pharmacogenetics and Molecular Ancestry ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Access to Blood Glucose Testing in Peru: Who Is Getting Tested?Epidemiologia (Basel, Switzerland) · 2025
    Article
  8. The Influence of DNA Repair Genes and Prenatal Tobacco Exposure on Risk of Childhood Acute Lymphoblastic Leukemia: A Gene-Environment Interaction Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Aroon T ChandeSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, GA, 30332, USA.
Lavanya RishishwarIHRC-Georgia Tech Applied Bioinformatics Laboratory, Atlanta, GA, USA.
Andrew B ConleyIHRC-Georgia Tech Applied Bioinformatics Laboratory, Atlanta, GA, USA.
Augusto Valderrama-AguirreSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, GA, 30332, USA.
Miguel A Medina-RivasPanAmerican Bioinformatics Institute, Cali, Valle del Cauca, Colombia.
I King JordanSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, GA, 30332, USA. king.jordan@biology.gatech.edu.ORCID 0000-0003-4996-2203
Georgia Institute of Technology · USTechnological University of Choco · CO

Funding

Fulbright Colombia (CO) 007Georgia Institute of Technology (US) RF383
6 · The paper itself

Abstract

backgroundHispanic/Latino (HL) populations bear a disproportionately high burden of type 2 diabetes (T2D). The ability to predict T2D genetic risk using polygenic risk scores (PRS) offers great promise for improved screening and prevention. However, there are a number of complications related to the accurate inference of genetic risk across HL populations with distinct ancestry profiles. We investigated how ancestry affects the inference of T2D genetic risk using PRS in diverse HL populations from Colombia and the United States (US). In Colombia, we compared T2D genetic risk for the Mestizo population of Antioquia to the Afro-Colombian population of Chocó, and in the US, we compared European-American versus Mexican-American populations.

methodsWhole genome sequences and genotypes from the 1000 Genomes Project and the ChocoGen Research Project were used for genetic ancestry inference and for T2D polygenic risk score (PRS) calculation. Continental ancestry fractions for HL genomes were inferred via comparison with African, European, and Native American reference genomes, and PRS were calculated using T2D risk variants taken from multiple genome-wide association studies (GWAS) conducted on cohorts with diverse ancestries. A correction for ancestry bias in T2D risk inference based on the frequencies of ancestral versus derived alleles was developed and applied to PRS calculations in the HL populations studied here.

resultsT2D genetic risk in Colombian and US HL populations is positively correlated with African and Native American ancestry and negatively correlated with European ancestry. The Afro-Colombian population of Chocó has higher predicted T2D risk than Antioquia, and the Mexican-American population has higher predicted risk than the European-American population. The inferred relative risk of T2D is robust to differences in the ancestry of the GWAS cohorts used for variant discovery. For trans-ethnic GWAS, population-specific variants and variants with same direction effects across populations yield consistent results. Nevertheless, the control for bias in T2D risk prediction confirms that explicit consideration of genetic ancestry can yield more reliable cross-population genetic risk inferences.

conclusionsT2D associations that replicate across populations provide for more reliable risk inference, and modeling population-specific frequencies of ancestral and derived risk alleles can help control for biases in PRS estimation.

Indexed as

Genetic Predisposition to DiseaseColombiaDiabetes Mellitus, Type 2Genome-Wide Association StudyHispanic or LatinoHumansPolymorphism, Single NucleotidePrevalenceRisk FactorsUnited StatesWhite PeopleAntioquiaChocóColombiaGenetic ancestryGenetic riskHispanic/Latino (HL)Polygenic risk score (PRS)Population geneticsType 2 diabetes (T2D)

Identifiers

PMID32580712
PMCPMC7315475
OpenAlexW3037745462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.